Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
27 Dec 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
DEF 14C
Information statement
9 Aug 23
PRE 14C
Preliminary information
28 Jul 23
D
$330.00 k in equity / debt, sold $330.00 k, 1 investor
13 Jul 23
S-1
IPO registration
3 Jul 23
8-K
Entry into a Material Definitive Agreement
30 Jun 23
8-K
Entry into a Material Definitive Agreement
2 Jun 23
8-K/A
Changes in Registrant's Certifying Accountant
18 May 23
8-K
Changes in Registrant's Certifying Accountant
17 May 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
14 Apr 23
NT 10-K
Notice of late annual filing
31 Mar 23
8-K
Departure of Directors or Certain Officers
12 Jan 23
DEF 14C
Information statement
21 Nov 22
10-Q
2022 Q3
Quarterly report
21 Nov 22
NT 10-Q
Notice of late quarterly filing
14 Nov 22
8-K
Departure of Directors or Certain Officers
28 Sep 22
10-Q
2022 Q2
Quarterly report
16 Aug 22
NT 10-Q
Notice of late quarterly filing
15 Aug 22
DEF 14C
Information statement
17 May 22
10-Q
2022 Q1
Quarterly report
13 May 22
PRE 14C
Preliminary information
6 May 22
8-K
ViCapsys Life Sciences Appoints Federico Pier as Chief Executive Officer
12 Apr 22
10-K
2021 FY
Annual report
16 Mar 22
10-Q
2021 Q3
Quarterly report
12 Nov 21
10-Q
2021 Q2
Quarterly report
20 Sep 21
10-Q
2021 Q1
Quarterly report
20 Sep 21
10-K
2020 FY
Annual report
17 Sep 21
10-Q
2020 Q3
Quarterly report
13 Sep 21
10-Q
2020 Q2
Quarterly report
9 Sep 21
10-Q
2020 Q1
Quarterly report
15 May 20
UPLOAD
Letter from SEC
6 Apr 20
10-12G/A
Registration of securities (amended)
30 Mar 20
UPLOAD
Letter from SEC
27 Mar 20
10-12G/A
Registration of securities (amended)
20 Mar 20
CORRESP
Correspondence with SEC
20 Mar 20
UPLOAD
Letter from SEC
11 Mar 20
10-12G
Registration of securities
12 Feb 20
Latest ownership filings
No filings